Genetic and Epigenetic Regulation of Phosphoinositide 3-kinase Isoforms

被引：7

作者：

Fyffe, Chanse ^{[1
]}

Buus, Richard ^{[1
]}

Falasca, Marco ^{[1
]}

机构：

[1] Queen Mary Univ London, Barts & London Sch Med & Dent, Inositide Signalling Grp, Ctr Diabet,Blizard Inst, London E1 2AT, England

来源：

CURRENT PHARMACEUTICAL DESIGN | 2013年 / 19卷 / 04期

关键词：

PI3K; genetic; epigenetic; cancer; SNP; mutations; regulation; PROTEIN-KINASE-B; PHOSPHATIDYLINOSITOL; 3-KINASE; CELL-PROLIFERATION; HIGH-FREQUENCY; PIK3CA GENE; SELECTIVE INHIBITOR; P110-ALPHA ISOFORM; DIFFERENTIAL ROLES; CATALYTIC SUBUNIT; GLUCOSE-TRANSPORT;

D O I：

10.2174/138161213804581873

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The last quarter of a century has witnessed remarkable progress in the understanding of phosphoinositide 3-kinases (PI3K) signalling and their involvement in different diseases such as cancer, diabetes and inflammation. Nevertheless, many questions remain open and among these the role of genetic and epigenetic regulation of PI3K isoforms is one of the most prominent. Emerging evidence Indicates that levels of isoforms can be modulated upon stimulation or in both physiological and pathological conditions including increased gene copy number and transcription regulation. In addition, an intriguing role for epigenetic regulation of PI3K expression, caused by mechanisms other than changes in the underlying DNA sequence, are starting to get appreciated. In this review, we summarize the genetic and epigenetic regulation of PI3Ks in physiology and the role played by their alterations in different diseases.

引用

页码：680 / 686

页数：7

共 113 条

[101] Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy [J].

Stratford, Anna L. ;

Habibi, Golareh ;

Astanehe, Arezoo ;

Jiang, Helen ;

Hu, Kaiji ;

Park, Eugene ;

Shadeo, Ashleen ;

Buys, Timon P. H. ;

Lam, Wan ;

Pugh, Trevor ;

Marra, Marco ;

Nielsen, Torsten O. ;

Klinge, Uwe ;

Mertens, Peter R. ;

Aparicio, Samuel ;

Dunn, Sandra E. .

BREAST CANCER RESEARCH, 2007, 9 (05)

[102] Genetic Variation Predicting Cisplatin Cytotoxicity Associated with Overall Survival in Lung Cancer Patients Receiving Platinum-Based Chemotherapy [J].

Tan, Xiang-Lin ;

Moyer, Ann M. ;

Fridley, Brooke L. ;

Schaid, Daniel J. ;

Niu, Nifang ;

Batzler, Anthony J. ;

Jenkins, Gregory D. ;

Abo, Ryan P. ;

Li, Liang ;

Cunningham, Julie M. ;

Sun, Zhifu ;

Yang, Ping ;

Wang, Liewei .

CLINICAL CANCER RESEARCH, 2011, 17 (17) :5801-5811

[103] p110 delta, a novel phosphoinositide 3-kinase in leukocytes [J].

Vanhaesebroeck, B ;

Welham, MJ ;

Kotani, K ;

Stein, R ;

Warne, PH ;

Zvelebil, MJ ;

Higashi, K ;

Volinia, S ;

Downward, J ;

Waterfield, MD .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) :4330-4335

[104] The emerging mechanisms of isoform-specific PI3K signalling [J].

Vanhaesebroeck, Bart ;

Guillermet-Guibert, Julie ;

Graupera, Mariona ;

Bilanges, Benoit .

NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2010, 11 (05) :329-341

[105] The phosphatidylinositol 3-kinase-AKT pathway in human cancer [J].

Vivanco, I ;

Sawyers, CL .

NATURE REVIEWS CANCER, 2002, 2 (07) :489-501

[106] PTEN-deficient cancers depend on PIK3CB [J].

Wee, Susan ;

Wiederschain, Dmitri ;

Maira, Sauveur-Michel ;

Loo, Alice ;

Miller, Christine ;

DeBeaumont, Rosalie ;

Stegmeier, Frank ;

Yao, Yung-Mae ;

Lengauer, Christoph .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (35) :13057-13062

[107] Ca2+-regulated Pool of Phosphatidylinositol-3-phosphate Produced by Phosphatidylinositol 3-Kinase C2α on Neurosecretory Vesicles [J].

Wen, Peter J. ;

Osborne, Shona L. ;

Morrow, Isabel C. ;

Parton, Robert G. ;

Domin, Jan ;

Meunier, Frederic A. .

MOLECULAR BIOLOGY OF THE CELL, 2008, 19 (12) :5593-5603

[108] ACTIVATION OF PHOSPHOINOSITIDE 3-KINASE IS REQUIRED FOR PDGF-STIMULATED MEMBRANE RUFFLING [J].

WENNSTROM, S ;

HAWKINS, P ;

COOKE, F ;

HARA, K ;

YONEZAWA, K ;

KASUGA, M ;

JACKSON, T ;

CLAESSONWELSH, L ;

STEPHENS, L .

CURRENT BIOLOGY, 1994, 4 (05) :385-393

[109]

WENNSTROM S, 1994, ONCOGENE, V9, P651

[110] Isoform-selective induction of human p110δ PI3K expression by TNFα: identification of a new and inducible PIK3CD promoter [J].

Whitehead, Maria A. ;

Bombardieri, Michele ;

Pitzalis, Costantino ;

Vanhaesebroeck, Bart .

BIOCHEMICAL JOURNAL, 2012, 443 :857-867

← 3 4 5 6 7 8 9 10 11 12 →